Australia, Oct. 7 -- Definium Therapeutics US Inc., owns the trademark (2661526) for 'NEUPLIXO' till April 17, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, generalized anxiety disorder (gad) and major depressive disorder (mdd).] and 05 [Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD)]
Type of Mark: Word
Date of Acceptance: June 25
Registration Advertised: Oct. 6
For further details contact John Paul Oleksiuk Cooley LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2661526.
Disclaimer: Curated by HT Syndication.
